SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...3M Acquires Ivera Medical Corp. for Undisclosed Price
Ivera Medical Corp., a San Diego-based company that makes products that disinfect and protect devices used to access a patient’s bloodstream, is being purchased by 3M Co. of St. Paul, Minn.
February 26, 2015 2:31 p.m. ShareOtonomy Submits Drug for FDA Approval
Otonomy Inc., a company that makes treatments for the middle and inner ear, has submitted a drug candidate for regulatory approval following encouraging Phase 3 data.
Isis Pharmaceuticals Reports Q4 Results
Isis Pharmaceuticals Inc. reported a significantly improved fourth quarter net income of $31 million, up from a net loss of $24.3 million in the same quarter last year.
Formula Is New CEO, New Home, Old Drug
BIOTECH: Investors See Good Bet in Heart Drug
San Diego’s abundance of intellectual capital and venture investors with deep pockets has lured yet another startup from its snow-steeped home to sunny Southern California.
Meritage Pharma Acquired by Drugmaker Shire for $70 Million
Dublin-based drugmaker Shire Plc has acquired San Diego-based Meritage Pharma for an upfront payment of $70 million, with another $175 million contingent on meeting milestones, according to a recent news release.
Chris Bernard Joins Epic Sciences as Chief Commercial Officer
Epic Sciences Inc., a San Diego-based diagnostics company, announced Wednesday the appointment of Chris Bernard as chief commercial officer.
Tandem Diabetes Care to Raise $60 Million in Underwritten Public Offering
Tandem Diabetes Care Inc., a medical device company and manufacturer of insulin pumps, announced in a statement Tuesday that it intends to raise $60 million in an underwritten public offering.
XIFIN Names James C. Malone Its New CFO
XIFIN Inc., a San Diego-based software and services company dedicated to optimizing the economics of health care, has named James C. Malone as its new chief financial officer.
Ligand Pharmaceuticals Reports 2014 Net Income of $12 Million
Ligand Pharmaceuticals Inc. reported net income of $12 million for the 2014 fiscal year, according to a recent regulatory filing.
Elcelyx Therapeutics Raises $5.8 Million in Financing
Elcelyx Therapeutics Inc., a biotechnology firm developing drugs for weight management and obesity-related metabolic disorders, has raised $5.8 million in a Series D financing round, according to a recent filing with the Securities and Exchange Commission.
AMN Healthcare Reports Q4 Net Income of $10 Million
The San Diego-based staffing company AMN Healthcare Services Inc. reported fourth-quarter net income of $10 million and net income per diluted share of $0.20. As a result, its stock increased nearly 14 percent to $22.96 per share.
Supreme Court Case Could Dismantle Health Care Law
Health Care Column
A looming Supreme Court case has put pressure on Congressional Republicans to design a new plan to replace President Obama’s signature health care law. But rather than develop new solutions, lawmakers seem to be producing more of the same. Out with the old, and… well, back in with the old.
Bastyr Fills Niche for Naturopathic Doctors
MEDICINE: Accredited School Is Seeing Increasing Enrollment
A new university in San Diego is training the next generation of primary care doctors in the state’s first and only accredited natural medicine school — Bastyr University.
OCTANe's CEO to Join UCSD Healthcare System
Matthew Jenusaitis will step down as president and chief executive officer of Aliso Viejo-based OCTANe to join the University of California San Diego Healthcare System.
Neurocrine Announces $225 Million Public Stock Offering
San Diego-based Neurocrine Biosciences Inc. has begun an underwritten public offering of shares of its common stock to raise aggregate proceeds of about $225 million.
-
prev
- next
